ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 525

The Genetic Basis of Sjögren’s Syndrome (SS) Clinical Manifestations from Genome-Wide Association Analysis of Subphenotype Extremes in an International Cohort

Lindsey A. Criswell1, Kimberly E. Taylor2,3, Quenna Wong4, David M. Levine4, Caitlin McHugh4, Cathy Laurie4, Kimberly Doheny5, Mi Y. Lam6, Alan N. Baer7, Stephen Challacombe8, Yi Dong9, Hector Lanfranchi10, Morten Schiødt11, M. Srinivasan12, Susumu Sugai13, Hisanori Umehara14, Frederick B. Vivino15, Zhao Yan16, Stephen Shiboski17, Troy Daniels18, John S. Greenspan6, Caroline H. Shiboski6 and Sjögren's Syndrome Collaborative Clinical Alliance (SICCA)19, 1Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 2Medicine, University of California San Francisco, San Francisco, CA, 3University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 4University of Washington, Biostatistics, Seattle, WA, 5Center for Inherited Disease Research, Baltimore, MD, 6Orofacial Sciences, University of California San Francisco, San Francisco, CA, 7Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 8Kings College London, London, United Kingdom, 9Dept of Rheumatology, Peking Univ Med Coll Hospital, East City Beijing, China, 10University of Buenos Aires, Buenos Aires, Argentina, 11Oral and Maxillofacial Surgery, Rigshospitalet, Copenhagen, Denmark, 12Aravind Eye Hospital, Madurai, India, 13Kanazawa Medical University, Ishikawa, Japan, 14Internal Medicine, Division of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan, 15Medicine, Penn Presbyt Med Ctr, Philadelphia, PA, 16Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China, 17Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, 18Orofacial Sciences, Box 0422, University of California San Francisco, San Francisco, CA, 19University of California San Francisco, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: autoimmune diseases, Genetic architecture, genomics and phenotypes, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Sjogren's Syndrome: Pathophysiology

Session Type: Abstract Submissions (ACR)

Background/Purpose Our goal is to define the contribution of genetic factors to two hallmark manifestations of SS, keratoconjunctivitis sicca (KCS) and focal lymphocytic sialadenitis (FLS), in an international cohort.

Methods We studied 3,334 participants in the Sjögren’s International Collaborative Clinical Alliance (SICCA; contract # HHSN 268201300057C) registry who were characterized for the Illumina HumanOmni 2.5-Quad marker set. SICCA participants were enrolled according to standardized protocols at 9 international sites, including Argentina (n=428), China (n=304), Denmark (n=583), India (n=127), Japan (n=367), the UK (n=296) and the US (total n=1229 from 3 sites). QC measures included filters based on SNP and sample missingness (≥ 2%), unexpected relatedness, non-Mendelian inheritance, and chromosomal regions of anomaly (> 10Mb).   SICCA participants were assessed for presence and severity of FLS defined by focus score (FS, positive ≥ 1) on minor salivary gland biopsy and degree of KCS based on ocular staining pattern measured by ocular staining score (OSS, positive ≥ 3). In order to investigate the genetic basis of these manifestations, we compared patients with high values (OSS ≥ 7, FS ≥ 2.5) to patients with normal values (OSS < 3, FS < 1) via logistic regression. Principal components analysis (PCA) was used to characterize each participant for genetic ancestry, and PCs 1 - 5 were included as covariates in all association analyses.  We analyzed the entire group and also the two largest strata by ethnicity (European and Asian, with outliers removed outside of PCA clusters).


Results Out of 3284 unrelated subjects with post-QC genotypes and sufficient clinical data, patients were categorized for analysis as follows: high FS (n=636), normal FS (n=1968), high OSS (n=1333), normal OSS (n=857).  A total of 1,550,200 SNPs with MAF ≥ 1% passed all QC filters and were fully analyzed. Not surprising in autoimmunity, the MHC was the most significantly associated with both traits in the full dataset (FS p=3e-22; OSS p=6e-12) and in Europeans (FS 375 SNPs p<5e-8, lowest 3e-17; OSS 60 SNPs p<5e-8, lowest p=4e-11).  However, in Asians the MHC appears to have much less importance.  There was only one suggestive MHC SNP (p=8e-6) for FS; the most associated FS gene in Asians was PTPRD, with 12 SNPs p<5e-6 (lowest p=1.8e-7).  Outside of the MHC, some genes appear to influence both phenotypes while others are trait-specific.  For example, IRF5 is the highest-associated region for FS (p=2e-7) but not suggestive for OSS. The XYLT1 region is the highest-associated region for OSS (p=1e-6) but is not implicated in FS.   On the other hand, STAT4 is among the most-associated regions for both FS (p=1e-6) and OSS (p=3e-6).

Conclusion These results demonstrate that the ocular (OSS) and oral (FS) manifestations of SS are influenced by both shared and trait-specific genetic factors. Furthermore the genetic profile appears to be quite different for both depending on ancestry, in particular when comparing European and Asian SS patients. Additional work including imputed genetic data and more extensive ancestry analysis will provide more power for extending these findings and fully characterizing the genetic contribution to SS.


Disclosure:

L. A. Criswell,
None;

K. E. Taylor,
None;

Q. Wong,
None;

D. M. Levine,
None;

C. McHugh,
None;

C. Laurie,
None;

K. Doheny,
None;

M. Y. Lam,
None;

A. N. Baer,
None;

S. Challacombe,
None;

Y. Dong,
None;

H. Lanfranchi,
None;

M. Schiødt,
None;

M. Srinivasan,
None;

S. Sugai,
None;

H. Umehara,
None;

F. B. Vivino,
None;

Z. Yan,
None;

S. Shiboski,
None;

T. Daniels,
None;

J. S. Greenspan,
None;

C. H. Shiboski,
None;

S. S. C. C. A. (SICCA),
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-genetic-basis-of-sjogrens-syndrome-ss-clinical-manifestations-from-genome-wide-association-analysis-of-subphenotype-extremes-in-an-international-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology